CASP3 and Miyoshi myopathy: Treatment of MM cells with SNG up to 1 μM resulted in a dose-dependent increase in the cellular levels of active caspase 3 and cleaved PARP in all cell lines (Figures 2B,C) while reaching to a saturation level at 2 and 4 μM of SNG treatment condition.